V
54
2
GIS
54
2
LH
48
2
TGT
52
2
KMI
65
-2
EXC
53
3
EQT
51
-5
MMC
60
3
SO
53
5
IBM
67
2
PNW
57
2
AAPL
55
2
MU
79
3
ETN
61
2
VMC
59
2
TRIP
52
2
PSA
37
2
CNP
55
3
STZ
49
2
FSLR
60
-10
V
54
2
GIS
54
2
LH
48
2
TGT
52
2
KMI
65
-2
EXC
53
3
EQT
51
-5
MMC
60
3
SO
53
5
IBM
67
2
PNW
57
2
AAPL
55
2
MU
79
3
ETN
61
2
VMC
59
2
TRIP
52
2
PSA
37
2
CNP
55
3
STZ
49
2
FSLR
60
-10
Financhill
Back

Eledon Pharmaceuticals, Inc. 10K Form

Sell
28

ELDN
Eledon Pharmaceuticals, Inc.

Last Price:
$1.58
Seasonality Move:
-1.34%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ELDN News And Ratings

See the #1 stock for the next 7 days that we like better than ELDN

ELDN Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-14.5M
Price / Cash Flow: 0
Annual Sales: $0.59
Price / Book: 3.33

Profitability

EPS (TTM): -1.20210
Net Income (TTM): $-79.8M
Gross Margin: $-359K
Return on Equity: -78.86%
Return on Assets: -51.14%

Eledon Pharmaceuticals, Inc. Earnings Forecast

Key Eledon Pharmaceuticals, Inc. Financial Ratios

  • Per Share Earnings over the last 13 years have been positive in 7 years.

Eledon Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ELDN
Website: eledon.com

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 6.74
Quick Ratio: 6.53

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ELDN Technical Analysis vs Fundamental Analysis

Sell
28
Eledon Pharmaceuticals, Inc. (ELDN) is a Sell

Is Eledon Pharmaceuticals, Inc. a Buy or a Sell?